Heart health check-ins for adults starting multiple myeloma treatment
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study looks at how to better monitor and manage heart health in people with multiple myeloma while they start a new treatment plan. It tests a heart risk check-in process with your care team to help catch and address any heart-related issues early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with multiple myeloma.
- You are 18 years old or older.
- You are getting ready to start a new round of multiple myeloma treatment — whether it's your first treatment or a treatment for cancer that has returned or stopped responding.
- Your oncology team expects to see you regularly for at least a year, so you can complete study check-ins at 3, 6, and 12 months.
- If you join the part of the study that includes random assignment, you must have a primary care doctor who can be contacted.
- You do not have a heart emergency that needs immediate special care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a new heart ultrasound test can measure heart side effects and overall outcomes in people with multiple myeloma who are treated with the RVd drug combination. It may help doctors better understand heart risks during treatment.
This study uses your self-reported symptoms (PRO) and wearable/device data to help improve care for people with relapsed multiple myeloma who are starting new treatment. It may help by providing insights about how you’re doing during therapy—without changing your cancer treatment in a study-specific way.
This study looks at different ways to treat people who are newly diagnosed with multiple myeloma that has a change in chromosome 1 (+1q). The goal is to find the best treatment plan based on each person's risk level.
This study uses wearable heart monitors to check for heart problems during cancer treatment. Participants wear a small patch that tracks their heart rhythm, helping doctors detect issues early.
This study tests whether remote monitoring and health coaching can improve quality of life in older adults with multiple myeloma who are experiencing fatigue. You'll use a tablet or smartphone to track symptoms and get support from a coach.
This study tests a new tool that helps doctors figure out your risk for heart problems after cancer treatment. If you join, you'll get a heart risk check and possibly see a heart specialist. This could help prevent heart issues later.
Hear when a new Multiple myeloma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.